Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-06 Sale | 2024-11-08 4:50 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 106,319 | $45.56 | $4,843,979 | 154,218 (Direct) | View |
| 2024-09-23 Sale | 2024-09-23 8:59 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 11,510 | $44 | $506,440 | 121,355 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 6:48 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 11,228 | $39.13 | $439,345 | 82,865 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 7:07 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 104,245 | $35.72 | $3,723,141 | 109,275 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 6:25 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 75,000 | $28.28 | $2,121,045 | 213,520 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:12 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 40,000 | $24.52 | $980,760 | 288,520 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 3:11 pm | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 1,616 | $10.13 | $16,370 | 122,884 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-06 Exercise | 2024-11-08 4:50 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 65,182 | $8.82 | 154,218 (Direct) | View |
| 2024-11-06 Exercise | 2024-11-08 4:50 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 13,875 | $6.57 | 154,218 (Direct) | View |
| 2024-11-06 Exercise | 2024-11-08 4:50 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 79,057 | $0 | 154,218 (Direct) | View |
| 2024-09-19 Option Award | 2024-09-23 8:59 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 25,000 | $0 | 121,355 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 6:48 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 25,000 | $0 | 82,865 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 7:07 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 104,245 | $8.82 | 109,275 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 7:07 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 104,245 | $0 | 109,275 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 6:25 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 75,000 | $8.82 | 213,520 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 6:25 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 75,000 | $0 | 213,520 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:12 pm | N/A N/A | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 40,000 | $8.82 | 288,520 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:12 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 40,000 | $0 | 288,520 (Direct) | View |
| 2024-01-20 Option Award | 2024-01-23 3:11 pm | N/A 2034-01-19 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 128,500 | $0 | 122,884 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-12 7:33 pm | N/A 2033-09-10 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 74,000 | $0 | 74,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 7,000 | $0 | 7,000 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 9:06 pm | N/A 2033-01-19 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 166,500 | $0 | 169,852 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:00 pm | N/A 2032-06-08 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2022-01-21 Option Award | 2022-03-15 9:18 pm | N/A 2032-01-20 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 131,250 | $0 | 131,250 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 6:21 pm | N/A 2031-06-16 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 47,664 | $0 | 47,664 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-04 5:06 pm | N/A 2031-02-01 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 92,000 | $0 | 92,000 (Direct) | View |
Ownership | 2020-06-11 8:24 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer | 0 | $0 | 284,427 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-16 6:03 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | MacLean Michael F Chief Financial Officer | 28,000 | $0 | 48,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:21 pm | N/A 2030-01-01 | AKCEA THERAPEUTICS INC. | AKCA | MacLean Michael F Chief Financial Officer | 57,000 | $0 | 57,000 (Direct) | View |